TNFRSF17 and Miyoshi myopathy: Although a number of monoclonal IgGs have been generated against BCMA, only one has been thoroughly structurally characterized, the chimaeric mouse/human J22.9-xi that showed substantial anti-tumor effects in an MM mouse model [18].